Antiviral News

Hantavirus pulmonary syndrome

Favipiravir (T-705) shown to be highly active against prominent agents of hantavirus pulmonary syndrome. Details in: Safronetz et. al., Antimocrobial Agents & Chemotherapy, 2013.


#theTemplate.getDirectEidtLink()#